Cormedix Stock Guidance

CRMDNASDAQ

$7.34

-3.43-31.85%

At close: -

$7.47

0.131.77%

After Hours: 7:59 PM EDT

Q4 2024 earnings were released today before the market open

Today's conference call ended over 19 hours ago Click to view past webcast

Guidance

Cormedix issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.

											Get Alert
01/07/2025	CRMD	Cormedix	Q4	2024	—	—	—	$31.00M	$31.00M	$19.97M	Get Alert
01/07/2025	CRMD	Cormedix	FY	2024	—	—	—	$43.00M	$43.00M	$32.25M	Get Alert

There have been no specific sales or earnings guidance reported for Cormedix in recent months.

Browse guidance and forecast on all stocks.